Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan

Second-line Helicobacter pylori (H. pylori) eradication with fluoroquinolone-containing triple therapy is one of the recommended treatment options, but neither 7-day nor 10-day regimens provide >90% success rates. The current retrospective study aimed to clarify the effects of 10-day and 14-day l...

Descripción completa

Detalles Bibliográficos
Autores principales: Tai, Wei-Chen, Chiu, Chien-Hua, Liang, Chih-Ming, Chang, Kuo-Chin, Kuo, Chung-Mou, Chiu, Yi-Chun, Wu, Keng-Liang, Hu, Ming-Luen, Chou, Yeh-Pin, Chiou, Shue-Shian, Chiu, King-Wah, Kuo, Chung-Huang, Hu, Tsung-Hui, Lin, Ming-Tsung, Chuah, Seng-Kee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819765/
https://www.ncbi.nlm.nih.gov/pubmed/24235968
http://dx.doi.org/10.1155/2013/932478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819765/
https://www.ncbi.nlm.nih.gov/pubmed/24235968
http://dx.doi.org/10.1155/2013/932478

Ejemplares similares